Status:
COMPLETED
Fasting for Brain and Heart Health (FBHH)
Lead Sponsor:
TrueNorth Health Foundation
Conditions:
Insulin Resistance
Eligibility:
All Genders
40-70 years
Brief Summary
This pilot study is designed to investigate the effect of water-only fasting and refeeding on the homeostatic model of insulin resistance (HOMA-IR), a measure of insulin resistance.
Detailed Description
Ischemic stroke is a leading cause of death and a major public health burden. Data suggests that insulin resistance is a potential risk factor for cardiovascular disease, including ischemic stroke, an...
Eligibility Criteria
Inclusion
- Any gender
- 40-70 years old
- Fasting plasma glucose \<12 6mg/dL and/or hemoglobin A1c \<7%
- Body Mass Index (BMI) \>25 kg/m2
- Elect and qualify for a water-only fast of at least 10 consecutive days
- Provide informed consent
Exclusion
- Active malignancy
- Active inflammatory disorder including classic autoimmune connective tissue (Lupus, Sjogrens, ANCA), multiple sclerosis, and inflammatory bowel disorders (Ulcerative colitis, Crohn's)
- Stroke or heart attack within the last 90 days
Key Trial Info
Start Date :
April 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04507516
Start Date
April 2 2019
End Date
February 10 2020
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TrueNorth Health Center
Santa Rosa, California, United States, 95404